Please assess the completion status of the following clinical trial:

Trial Title: Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who will start with an angiogenesis inhibitor or EGFR inhibitor~* Concomittant chemotherapy, immunotherapy or radiotherapy is allowed~* Age above 18 years at start of treatment~* Willingness to give written informed consent~Exclusion Criteria:~* Unable to give written informed consent~* Age under 18 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).